CD19 is uniformly expressed across all B-cell lymphomas, including DLBCL; it even survives on small subsets of CD20-negative B-cell lymphomas evolving after anti-CD20 immunotherapy [406,407]. The gene discussed is CD19; the disease is diffuse large B-cell lymphoma.